These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 23642183)

  • 41. Is neurogenesis relevant in depression and in the mechanism of antidepressant drug action? A critical review.
    Tang SW; Helmeste D; Leonard B
    World J Biol Psychiatry; 2012 Sep; 13(6):402-12. PubMed ID: 22175526
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders.
    Witkin JM; Tzavara ET; Davis RJ; Li X; Nomikos GG
    Trends Pharmacol Sci; 2005 Dec; 26(12):609-17. PubMed ID: 16260047
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The Therapeutic Potency of Natural Products against Heart Failure].
    Sunagawa Y
    Yakugaku Zasshi; 2020; 140(4):471-477. PubMed ID: 32238626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Editorial: Natural and Synthetic Polyphenols as Emerging Drugs: Design, Delivery Systems and Preclinical & Clinical Therapeutic Approaches.
    Puig T
    Curr Drug Targets; 2017; 18(2):134. PubMed ID: 28264643
    [No Abstract]   [Full Text] [Related]  

  • 45. Ion channels as potential targets for the treatment of depression.
    Lodge NJ; Li YW
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):633-41. PubMed ID: 18729015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Advances in antidepressants and research methods of depression].
    Yang XY; Chen J; Yang XM; Ma SP
    Zhongguo Zhong Yao Za Zhi; 2007 May; 32(9):770-4. PubMed ID: 17639970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mouse models for studying depression-like states and antidepressant drugs.
    Bergner CL; Smolinsky AN; Hart PC; Dufour BD; Egan RJ; Laporte JL; Kalueff AV
    Methods Mol Biol; 2010; 602():267-82. PubMed ID: 20012404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis.
    Krass M; Wegener G; Vasar E; Volke V
    Behav Brain Res; 2011 Mar; 218(1):57-63. PubMed ID: 21093491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plant polyphenols as natural drugs for the management of Down syndrome and related disorders.
    Vacca RA; Valenti D; Caccamese S; Daglia M; Braidy N; Nabavi SM
    Neurosci Biobehav Rev; 2016 Dec; 71():865-877. PubMed ID: 27826066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin.
    Yi LT; Xu HL; Feng J; Zhan X; Zhou LP; Cui CC
    Physiol Behav; 2011 Jan; 102(1):1-6. PubMed ID: 20951716
    [TBL] [Abstract][Full Text] [Related]  

  • 51. sigma-1 receptors in major depression and anxiety.
    Kulkarni SK; Dhir A
    Expert Rev Neurother; 2009 Jul; 9(7):1021-34. PubMed ID: 19589051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circadian rhythms and treatment implications in depression.
    Monteleone P; Martiadis V; Maj M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1569-74. PubMed ID: 20691746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T; Lewitzka U; Sasse J; Adli M; Köberle U; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comorbid alcohol and substance abuse dependence in depression: impact on the outcome of antidepressant treatment.
    Ostacher MJ
    Psychiatr Clin North Am; 2007 Mar; 30(1):69-76. PubMed ID: 17362804
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pharmacological characterization and mechanisms of the novel antidepressive- and/or anxiolytic-like substances identified from Perillae Herba].
    Tsuji M; Miyagawa K; Takeuchi T; Takeda H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):159-67. PubMed ID: 18800619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior.
    Schmidt HD; Duman RS
    Behav Pharmacol; 2007 Sep; 18(5-6):391-418. PubMed ID: 17762509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brain correlates of antidepressant treatment outcome from neuroimaging studies in depression.
    Dougherty DD; Rauch SL
    Psychiatr Clin North Am; 2007 Mar; 30(1):91-103. PubMed ID: 17362806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cysteamine-related agents could be potential antidepressants through increasing central BDNF levels.
    Tsai SJ
    Med Hypotheses; 2006; 67(5):1185-8. PubMed ID: 16797865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
    Dhir A; Malik S; Kessar SV; Singh KN; Kulkarni SK
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):705-14. PubMed ID: 21277753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.